Treatment of heroin dependence with buprenorphine in primary care. - Wikidata - awgldk - TriplyDB

Treatment of heroin dependence with buprenorphine in primary care.

Treatment of heroin dependence with buprenorphine in primary care.

http://www.wikidata.org/entity/Q39602688

about

Non-Medical Prescription Opioid Use and Prescription Opioid Use Disorder: A Review A multi-site, two-phase, Prescription Opioid Addiction Treatment Study (POATS): rationale, design, and methodology Buprenorphine treatment in an urban community health center: what to expect Home- versus office-based buprenorphine inductions for opioid-dependent patients.Impact of research network participation on the adoption of buprenorphine for substance abuse treatment.Conducting clinical research with prescription opioid dependence: defining the population.Factors affecting willingness to provide buprenorphine treatment.Opioid dependence treatment: options in pharmacotherapy.Patients' Reasons for Choosing Office-based Buprenorphine: Preference for Patient-Centered Care.Integrating buprenorphine treatment into office-based practice: a qualitative study Buprenorphine: new treatment of opioid addiction in primary care.A preliminary randomized controlled trial of a distress tolerance treatment for opioid dependent persons initiating buprenorphine The association between cocaine use and treatment outcomes in patients receiving office-based buprenorphine/naloxone for the treatment of opioid dependence.Prevention of HIV infection among injection drug users in resource-limited settings.Canadian guideline for safe and effective use of opioids for chronic noncancer pain: clinical summary for family physicians. Part 2: special populations.Patient satisfaction with primary care office-based buprenorphine/naloxone treatment.HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite study.Long-term outcomes of office-based buprenorphine/naloxone maintenance therapy.Primary care office-based buprenorphine treatment: comparison of heroin and prescription opioid dependent patients.A multi-level analysis of counselor attitudes toward the use of buprenorphine in substance abuse treatment Treating Opioid Dependence with Buprenorphine in the Safety Net: Critical Learning from Clinical Data.Provider satisfaction with office-based treatment of opioid dependence: a systematic review.Evidenced-based treatment of opioid-dependent patients.A randomized trial of cognitive behavioral therapy in primary care-based buprenorphine.Adoption of medications in substance abuse treatment: priorities and strategies of single state authorities A pilot study of a distress tolerance treatment for opiate-dependent patients initiating buprenorphine: rationale, methodology, and outcomes Counselor training and attitudes toward pharmacotherapies for opioid use disorder.Buprenorphine/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviors.Intersection of chronic pain treatment and opioid analgesic misuse: causes, treatments, and policy strategies.Comorbid pain and opioid addiction: psychosocial and pharmacological treatments.Primary Care-Based Models for the Treatment of Opioid Use Disorder: A Scoping Review.Integrating buprenorphine treatment into a public healthcare system: the San Francisco Department of Public Health's office-based Buprenorphine Pilot Program.Primary care models for treating opioid use disorders: What actually works? A systematic review Comparison of tuberculin skin testing reactivity in opioid-dependent patients seeking treatment with methadone versus buprenorphine: policy implications for tuberculosis screening.Coordination of medical care and opioid dependence treatment in primary care: a case report.Research to practice: adoption of naltrexone in alcoholism treatment.Lignes directrices canadiennes sur l’utilisation sécuritaire et efficace des opioïdes pour la douleur chronique non cancéreuse: Résumé clinique pour les médecins de famille. Partie 2: populations particulières.Neuropsychological functioning of opiate-dependent patients: a nonrandomized comparison of patients preferring either buprenorphine or methadone maintenance treatment.Treatment and Prevention of Opioid Use Disorder: Challenges and Opportunities.Preventing Opioid Overdose in the Clinic and Hospital: Analgesia and Opioid Antagonists

P2860

Q26785483-7CB1F0B5-43F4-4031-86F1-0C0EEF6E5CBB Q33699066-638BE67E-AB80-46F9-8C5A-D011C48486F1 Q33735289-33377385-EA6A-48C1-A5AB-3813B9739F0A Q33769847-CD4670A8-B039-43E4-9ACC-4FEB43F6D70D Q33776944-AF9E593C-798B-4BD5-84E6-52B74F1EBE2D Q33779302-015083DE-DF6F-4292-9F44-A045829575CD Q33836333-7270F27E-7F45-4D49-9031-D7635C694B41 Q33868638-3AD337DC-06A4-4FD1-8BD8-B3075CCEF67B Q34408522-3CA10A38-080C-4378-B13F-D7DD682D3DD4 Q34602077-4C0D4EDF-51F4-45F2-8238-CD426294AEE0 Q34667890-F1B63705-ECEC-46D4-817E-6F158A55EB40 Q34980314-7AE93D25-0BAD-4F1A-999A-DE2FBAC12325 Q35023292-66CBBC3E-6214-4217-899D-1A5FC0CC34F3 Q35043964-297F24BD-4D86-461C-BDEF-2A66A10E1F13 Q35548503-5AC09709-9D09-48D8-9D73-1FC69F2711F2 Q35683154-E7A9E609-966F-491D-AAFD-D81A22B821E0 Q35686969-B4F9D5E0-C08B-49CC-9200-57D1C47289EB Q35687716-4E46EDD6-5084-4055-8430-890C07B0E98A Q35691511-30D08FAB-B0F2-4B06-ACC5-9EA23B303E32 Q36364490-445F9B11-58B2-4A79-9E0C-73F8FC99376B Q36367544-F0449C36-CFAB-461C-9849-147FEC4340EC Q36402982-F6E29C1B-036D-4BBC-9D6F-469459EB98E6 Q36628470-A7EE106B-82C4-48AE-89AC-E36760BD6D60 Q36753425-D35D2B16-DD93-4568-96E0-3701A51F981E Q36806539-A7D1D22E-F1F0-4684-9BB2-8E3C4DEF90FD Q36926561-0921CD9B-A60A-45C7-ADA2-D6B3192310D2 Q36934945-6F2E7045-26A3-4680-A41B-F9B77B34773C Q36984354-703D1433-68D8-4754-BE11-5FEC8C146974 Q37355278-442BB4D6-CC03-432C-ADA5-C0589A3C1357 Q37901021-E4F1A859-B13A-4F88-B1FD-228FF7B79271 Q39029605-2DB73772-C664-4F8C-8F16-C55AFDE764F6 Q39995581-B3EF9FD8-56A5-4A7E-934E-B34004DBFC95 Q42656779-DE903EBD-5924-4C47-914F-3FC23808CBDF Q43218767-E9FB50CB-7F83-461E-82FA-0AFFAAF6674A Q44340899-CE02C5C6-11EB-43DA-9473-B6F355DEA51C Q44368411-B0AFDFD2-745F-4685-9819-048CC004D562 Q45871173-B5C88583-B62B-4DE1-89D3-55FBF4309B6C Q46416517-3652D48A-56D3-4FFA-8C10-B14499DFEC37 Q47561425-6E92D27E-E474-414B-A14E-C97272BB72D8 Q57128664-E64078B0-EDC7-46AF-8A41-3A855398EB02

P2860

Treatment of heroin dependence with buprenorphine in primary care.

http://www.wikidata.org/entity/Q39602688

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

2002年论文

@zh

2002年论文

@zh-cn

name

Treatment of heroin dependence with buprenorphine in primary care.

@en

Treatment of heroin dependence with buprenorphine in primary care.

@nl

type

label

Treatment of heroin dependence with buprenorphine in primary care.

@en

Treatment of heroin dependence with buprenorphine in primary care.

@nl

prefLabel

Treatment of heroin dependence with buprenorphine in primary care.

@en

Treatment of heroin dependence with buprenorphine in primary care.

@nl

P1433

Q39602688-FD41849C-5070-48A5-BAA8-409377A2D9B2

P1476

Q39602688-F1F4961B-71BC-494F-89F4-206500D21D7A

P2093

Q39602688-00C944AE-9C11-450E-ACA7-7ADD4E5396F9

Q39602688-39806425-4FC0-4370-A89E-89D3FE0562E1

Q39602688-48AA2D24-B68D-4947-BB8C-F96FC759458C

Q39602688-C855BD26-94CF-4AD4-92A3-C2F872EEE150

Q39602688-E91FBD7B-3AA9-49F2-85F9-B72F378E6C57

P2860

Q39602688-1AF2C2F2-A971-47E1-BAFF-01740CADA1C1

Q39602688-215AB04A-E990-45FD-99C3-75F7FB25CDFE

Q39602688-30F8034A-D568-4D0D-87CF-FFD622689FD4

Q39602688-4B0C44A9-13E9-4521-9F26-2CC09B9FFB26

Q39602688-8A92ED24-FD87-4287-994B-F2E4B6377611

Q39602688-A069C62F-F655-4942-99BB-CF064599FB11

Q39602688-A8969759-9AF3-4AEF-A0DD-4C82EC3A705E

Q39602688-B073C082-7A24-4536-9BC5-5A4702960210

Q39602688-C2D65226-DDCD-46FC-9BCA-64F9FF69BADA

Q39602688-CFBC6CA8-4D11-4420-9DA8-D592F5647BB3

P304

Q39602688-A6B8D4DE-C932-41DD-92DF-96CDD2BD3C4A

P31

Q39602688-FD826B47-5B26-43FC-86C4-FAAF1F7D5701

P356

Q39602688-D2707523-BF2C-4C4F-A187-9A54ABAFAED3

P433

Q39602688-922803F4-E593-4757-922C-3159DF550217

P478

Q39602688-78651073-B86C-4C81-A1CB-9688EE9A7805

P50

Q39602688-D7DBA509-426A-45B7-86BA-91BF6E68C192

P577

Q39602688-1C50439B-3782-4E42-A552-21F503DD8DE7

P698

Q39602688-3F48E201-549C-4D70-9F19-5DB459A174C0

P356

P1433

American Journal of Drug and Alcohol Abuse

P1476

Treatment of heroin dependence with buprenorphine in primary care.

@en

P2093

Juliana P Pakes

http://www.w3.org/2001/XMLSchema#string

Marek Chawarski

http://www.w3.org/2001/XMLSchema#string

Michael V Pantalon

http://www.w3.org/2001/XMLSchema#string

Patrick G O'Connor

http://www.w3.org/2001/XMLSchema#string

Richard S Schottenfeld

http://www.w3.org/2001/XMLSchema#string

P2860

The MOS 36-ltem Short-Form Health Survey (SF-36)

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study

Clinical pharmacology of buprenorphine: ceiling effects at high doses.

Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction.

Rapid and ultrarapid opioid detoxification techniques.

A pilot study of primary-care-based buprenorphine maintenance for heroin dependence.

Primary care-based ambulatory opioid detoxification: the results of a clinical trial.

Three methods of opioid detoxification in a primary care setting. A randomized trial.

Medical maintenance: a pilot study.

P304

231-241

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1081/ADA-120002972

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P50

David A. Fiellin

P577

2002-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12014814

http://www.w3.org/2001/XMLSchema#string